"Das Klinikum Kassel ist mit 32 Fachkliniken und Instituten das größte kommunale Krankenhaus der Maximalversorgung in Hessen und das Kompetenzzentrum für die medizinische Versorgung der Region. Jedes Jahr versorgt das Klinikum Kassel rund 55.000 Patientinnen und Patienten stationär und mehr als 140.000 ambulant. Das hochspezialisierte Leistungsspektrum aller medizinischer Disziplinen garantiert fachübergreifende und ganzheitliche Diagnose- und Therapiekonzepte mit einem Höchstmaß an Qualität. Rund 3.200 Mitarbeiterinnen und Mitarbeiter bieten unseren Patientinnen und Patienten höchsten medizinischen und pflegerischen Standard. Das Klinikum Kassel ist einer der größten Arbeitgeber und ein wichtiger Ausbilder in der Region."

During the past decade, Klinikum Kassel conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Kassel" #1 sponsor was "Aktion Bronchialkarzinom e.V." with 4 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "University Hospital Tuebingen" with 3 trials sponsored and "AGO Research GmbH" with 3 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Kassel" #1 collaborator was "Guidant Corporation" with 3 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Boehringer Ingelheim" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator. Other collaborators include 128 different institutions and companies that were collaborators in the rest 137 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Kassel" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Leukemia" (3 trials), "Neuroblastoma" (3 trials), "Ovarian Cancer" (3 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Klinikum Kassel" in a lesser frequency.

Most popular intervention types in "Klinikum Kassel" are "Drug" (40 trials), "Biological" (14 trials), "Radiation" (10 trials), "Procedure" (8 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (6 trials), "carboplatin" (5 trials), "cyclophosphamide" (5 trials), "filgrastim" (5 trials) and "ifosfamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Kassel" are 49 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum Kassel". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Klinikum Kassel, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Kassel, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Klinikum Kassel has several departments that took part in Clinical trials: "Klinikum Kassel; Hautklinik" - 3 trials, "Klinikum Kassel Gesundheit Nordhessen Holding AG, Klinik für pädiatrische Hämatologie und Onkologie" - 2 trials